allcancercure.com

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced the initiation by Merck & Co. Inc., of a Phase 2 clinical trial to evaluate the safety and efficacy of oral deforolimus, ARIAD‘s investigational mTOR inhibitor, in patients with advanced non-small cell lung cancer. Deforolimus is currently being studied in multiple clinical trials, both alone and in combination with [...]

Mesothelioma is a from of lung cancer that is almost always caused by asbestos exposure and is most commonly found in the outer lining of the lungs called the mesothelium. A majority of the people who develop mesothelioma contract this cancer through breathing in asbestos fibers or being exposed to asbestos dust while on the [...]

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radiosurgery in the United States grew 52 percent from calendar year 2007 to 2008 and 43 percent worldwide. Additionally the overall [...]

What is lung cancer? Lung cancer starts when abnormal cells grow out of control in the lung. They can invade nearby tissues and form tumors. Lung cancer can start anywhere in the lungs and affect any part of the respiratory system. The cancer cells can spread, or metastasize, to the lymph nodes and other parts [...]

Research involving more than a million middle-age women finds that even moderate drinking raises risks for breast, liver and other cancers. “Even relatively low levels of drinking – on the order of one alcoholic drink per day — increase a woman’s risk of developing cancer,” said lead researcher Naomi Allen, from the cancer epidemiology unit [...]

A previously unknown effect of an infectious agent relevant to the prevention and/or treatment of lung cancer has been discovered by a UMDNJ research team led by Melissa Rogers, Ph.D., professor of Biochemistry and Molecular Biology at UMDNJ-New Jersey Medical School. The infectious agent, mycoplasma bacterium, induces the synthesis of an important growth factor, BMP2, [...]

Europeans with the least education have a higher incidence of lung cancer compared with those with the highest education. However, smoking history accounts for approximately half of this risk, according to a study in the February 24 online issue of the Journal of the National Cancer Institute. Previous studies showed that individuals with a lower [...]

A group of scientists led by Professor Xavier Pares of the Department of Biochemistry and Molecular Biology at Universitat Autonoma de Barcelona, has published research on AKR1B10, an enzyme that is detected in large quantities only in lung cancers, particularly those caused by smoking. This enzyme can appear even when the cancer has not yet [...]

One of the deadliest forms of cancer appears to carry a specific weakness. When a key gene called 14-3-3zeta is silenced, lung cancer cells can’t survive on their own, researchers have found. The gene is a potential target for selective anti-cancer drugs, says Haian Fu, PhD, professor of pharmacology, hematology & oncology at Emory University [...]

Hayley McDaid, Ph.D. assistant professor of medicine and of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, has received a $100,000 grant from Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer for her research of lung cancer. The grant, which is being funded equally over two years by Joan’s Legacy [...]